Status:
COMPLETED
Studies of Mothers With Postnatal Depression
Lead Sponsor:
University College, London
Conditions:
Postnatal Depression
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
This study investigates the effects of a single dose of oxytocin (OT) delivered via a nasal spray in women with and without traits of postnatal depression (PND).
Detailed Description
A double-blind, placebo-controlled, case-controlled, randomised controlled-trial, within-subjects, cross-over design will be conducted. Participants will include mothers and their infant in the postn...
Eligibility Criteria
Inclusion
- All mothers will be aged ≥18 years old.
- Mothers in the clinical group will score above the clinical cut-off point on the EPDS.
- Mothers in the control group will score below the clinical cut-off point on the EPDS.
- Mothers must be able to read and write English at a level sufficient to complete study related assessments.
Exclusion
- If the mother is younger than 18 or post-menopausal
- If the pregnancy was a result of fertility treatment
- If the mother is pregnant
- If the mother has history of psychotic illness
- If the mother is at risk of self-harm
- If the mother is involved in other active drug trials
Key Trial Info
Start Date :
May 12 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04745494
Start Date
May 12 2017
End Date
January 30 2021
Last Update
February 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University College London
London, UK, United Kingdom, WC1E 7HB